MedPath

A Study To Evaluate Effectiveness and Safety of Dosulepin hydrochloride in Patients with Major Depressive Disorder

Phase 4
Completed
Conditions
Health Condition 1: F339- Major depressive disorder, recurrent, unspecifiedHealth Condition 2: F329- Major depressive disorder, singleepisode, unspecified
Registration Number
CTRI/2018/10/016217
Lead Sponsor
Dr M Suresh Kumar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex in the age group of 18-65 years.

2.Patient willing to participate in the study and sign an informed consent form.

3.Patients with the diagnosis of the Depressive episode (Single episode or recurrent) (by ICD-10 DCR) without psychotic symptoms.

4.Exhibiting treatment non-response (less than 50% reduction in depressive symptoms) after four weeks of treatment with SSRIs, during which the patient has had an adequate dose for at least three weeks.

5.A condition of general good physical health.

6.Patients with no cognitive impairments and having Mini-Mental State Examination (MMSE) scale score of >=24.

Exclusion Criteria

1.Patients with the Depressive episode (by ICD-10 DCR) with psychotic symptoms.

2.Patients who underwent electroconvulsive therapy within 2 months.

3.Pregnant and nursing women.

4.Women with childbearing potential who are not practicing a reliable method of birth control.

5.Patients with comorbid substance abuse or history of organicity.

6.Patients with a history of the Obsessive-compulsive disorder.

7.Patients with a history of major medical or neurological illness.

8.Patients with recent myocardial infarction, any degree of heart block or other cardiac arrhythmias.

9.Patients with the severe liver disease.

10.Suspected inability or unwillingness to comply with study procedures.

11.Known intolerance to any of the ingredients of Dosulepin.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath